Civic Intelligence

Cohen Veterans Bioscience Inc.

990 • Fiscal year 2022 • EIN 47-1981973

Jul 01, 2021 to Jun 30, 2022 • Filed on Apr 28, 2023

Organization ProfileWWW.COHENVETERANSBIOSCIENCE.ORG

View Organization Page

535 8th Avenue 12th FloorNew York, NY 10018

(646) 970-4325

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

57th percentile

0.24x

Higher debt load relative to assets than 57% of similar nonprofits.

2022 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2022

Liabilities / Revenue

49th percentile

0.20x

Higher debt load relative to revenue than 49% of similar nonprofits.

2022 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2022

Net Margin

41st percentile

3.1%

Higher net margin than 41% of similar nonprofits.

2022 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2022

Top Officer Pay

94th percentile

$656,806

Higher top officer pay than 94% of similar nonprofits.

Top officer pay equals 3.6% of source-year revenue.

2022 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2022

Asset Growth

13th percentile

-13%

Faster asset growth than 13% of similar nonprofits.

2022 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2021 to 2022

Revenue Growth

62nd percentile

11%

Faster revenue growth than 62% of similar nonprofits.

2022 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2021 to 2022

Balance Sheet
Liabilities / Assets57th percentile

Assets

Down

$15,587,351

Down $2,365,233 (-13%) from 2021

Net Assets

Up

$11,887,525

Up $761,464 (+6.8%) from 2021

Liabilities

Down

$3,699,826

Down $3,126,697 (-46%) from 2021

Revenue And Expenses
Liabilities / Revenue49th percentileNet Margin41st percentile

Revenue

Up

$18,082,398

Up $1,830,128 (+11%) from 2021

Expenses

Down

$17,523,784

Down $586,636 (-3.2%) from 2021

Net Income

Up

$558,614

Up $2,416,764 (+130%) from 2021

Historical Trend

Balance Sheet Trend

Asset Growth13th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$30M$20M$10M$0-$10MAssets 2015: $450,595Liabilities 2015: $326,443Net Assets 2015: $124,1522015Assets 2016: $25,419,016Liabilities 2016: $10,161,873Net Assets 2016: $15,257,1432016Assets 2017: $14,863,415Liabilities 2017: $6,579,459Net Assets 2017: $8,283,9562017Assets 2018: $16,353,364Liabilities 2018: $6,020,527Net Assets 2018: $10,332,8372018Assets 2019: $24,190,269Liabilities 2019: $12,988,921Net Assets 2019: $11,201,3482019Assets 2020: $18,865,456Liabilities 2020: $8,431,760Net Assets 2020: $10,433,6962020Assets 2021: $17,952,584Liabilities 2021: $6,826,523Net Assets 2021: $11,126,0612021Assets 2022: $15,587,351Liabilities 2022: $3,699,826Net Assets 2022: $11,887,5252022Assets 2022: $15,587,351Liabilities 2022: $3,699,826Net Assets 2022: $11,887,5252022Assets 2023: $11,743,398Liabilities 2023: $3,853,705Net Assets 2023: $7,889,6932023Assets 2024: $3,075,275Liabilities 2024: $3,105,844Net Assets 2024: -$30,5692024Assets 2025: $1,835,419Liabilities 2025: $98,368Net Assets 2025: $1,737,0512025

Highlighted filing

2022

Assets$15,587,351
Liabilities$3,699,826
Net Assets$11,887,525
Open 2022 Filing

Operations Trend

Revenue Growth62nd percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$40M$30M$20M$10M$0-$10MRevenue 2015: $70,035Expenses 2015: $651,553Net Income 2015: -$581,5182015Revenue 2016: $31,399,759Expenses 2016: $16,266,768Net Income 2016: $15,132,9912016Revenue 2017: $4,366,629Expenses 2017: $11,339,816Net Income 2017: -$6,973,1872017Revenue 2018: $16,845,541Expenses 2018: $14,796,660Net Income 2018: $2,048,8812018Revenue 2019: $21,039,448Expenses 2019: $20,170,937Net Income 2019: $868,5112019Revenue 2020: $16,470,665Expenses 2020: $18,162,920Net Income 2020: -$1,692,2552020Revenue 2021: $16,252,270Expenses 2021: $18,110,420Net Income 2021: -$1,858,1502021Revenue 2022: $18,082,398Expenses 2022: $17,523,784Net Income 2022: $558,6142022Revenue 2022: $18,082,398Expenses 2022: $17,523,784Net Income 2022: $558,6142022Revenue 2023: $11,343,534Expenses 2023: $15,341,366Net Income 2023: -$3,997,8322023Revenue 2024: $8,377,751Expenses 2024: $14,079,910Net Income 2024: -$5,702,1592024Revenue 2025: $3,369,809Expenses 2025: $1,377,761Net Income 2025: $1,992,0482025

Highlighted filing

2022

Revenue$18,082,398
Expenses$17,523,784
Net Income$558,614
Open 2022 Filing
Jump To
Filing Snapshot
Filing Period
Jul 1, 2021 to Jun 30, 2022
Signed
Apr 28, 2023
Return Version
2021v4.2
Gross Receipts
$18,082,398
Mission and Program Overview

Mission

Cohen veterans bioscience is the only 501(c)3 non-profit research organization with a singular focus on ptsd and tbi research. We are dedicated to fast-tracking the development of diagnostic tests and personalized medicines for the millions of veterans and civilians who suffer the devastating effects of trauma on the brain.

Biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.

Balance Sheet Detail
LineBeginningEndChange
Assets
Pledges and Grants Receivable$4,776,718$8,295,108▲ $3,518,390
Savings and Temporary Cash Investments$11,484,429$3,831,713▼ $7,652,716
Land, Buildings, and Equipment, Net$234,254$1,432,920▲ $1,198,666
Cash and Non-Interest-Bearing Accounts$654,129$999,648▲ $345,519
Prepaid Expenses and Deferred Charges$268,785$123,073▼ $145,712
Accounts Receivable-$21,300-
Total Assets$17,952,584$15,587,351▼ $2,365,233
Other Assets Total$534,269$883,589▲ $349,320
Liabilities
Accounts Payable and Accrued Expenses$2,078,653$2,682,753▲ $604,100
Grants Payable$4,606,870$877,731▼ $3,729,139
Other Liabilities$141,000$139,342▼ $1,658
Total Liabilities$6,826,523$3,699,826▼ $3,126,697
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$3,420,094$7,257,190▲ $3,837,096
Net Assets With Donor Restrictions$7,705,967$4,630,335▼ $3,075,632
Total Net Assets Fund Balance$11,126,061$11,887,525▲ $761,464
Total Liabilities and Net Assets / Fund Balance$17,952,584$15,587,351▼ $2,365,233

Asset Categories

AssetBook ValueDepreciationBasis
Other Land Buildings$1,246,171$74,351$1,320,522
Equipment$101,556$72,520$174,076
Leasehold Improvements$85,193$49,169$134,362
Other Assets Org$883,589--
Compensation and Service Providers
Top Officer Pay94th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Magali Haas Md PhdCEO & PresidentFT$479,600$177,206$656,806
Allyson Gage PhdChief Medical OfficerFT$378,411$152,703$531,114
Andreas Jeromin PhdChief Scientific OfficerFT$360,696$104,121$464,817
Lee LancashireChief Information OfficerFT$218,125$218,123$436,248
Evgeny RakhmatulinChief Technology OfficerFT$235,855$143,435$379,290
Amanda Nicole HarmonChief Operations OfficerFT$256,069$75,156$331,225
Kersten SmallDeputy Director, Translational RndFT$240,970$71,937$312,907
Renee DavisExecutive Director, DevelopmentFT$256,286$55,572$311,858
Maryan ZirkleExecutive Director, BraincommonsFT$233,619$76,592$310,211
Lauren GoldsmithSenior Director, ContractsFT$216,861$26,589$243,450
Mark ZervasDeputy Director, Translational ScienceFT$177,660$43,678$221,338
Mark ZervasDeputy Director, Translational Scien-$162,460$58,878$221,338

Board Members and Trustees

NameTitle
Dave DemarcoBoard Member
David BiondiBoard Member
Douglas HaynesFormer Board Member
Theresa FrangiosaSecretary
Michael SullivanTreasurer

Highest Paid Contractors

ContractorServicesLocationCompensation
Hitachi Vantara LLCCloud-based Architecture Build And Manag2535 AUGUSTINE DRIVE, Santa Clara, CA 95054-3003, Uk$861,974
Waveaccess USAResources For Brain Commons And Early Si10161 WEST RUN PARK DRIVE SUITE 15, Las Vegas, NV 89145$701,210
Grf Cpa's & AdvisorsAccounting And Bookkeeping1701 MARKET STREET, Philadelphia, PA 19103$321,233
Morgan Lewis And Bockius LLPLegal Services63 PUTNAM STREET SUITE 202, Sarasota Springs, NY 12866$273,913
Tone Creative LLCMarketing And Design Services-$239,234
Revenue and Support

Revenue Composition

Contributions and Grants
$17,941,055
Program Service Revenue
$0
Investment Income
$28,608
Other Revenue
$112,735
All Other Contributions
$17,856,836
Change in Net Assets
$558,614

Audited Revenue Reconciliation

Revenue per Audited Statements
$18,082,398
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$0
Total Revenue per Audited Statements
$18,082,398
Total Revenue per Form 990
$18,082,398
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$9,439,104
Salaries, Compensation, and Employee Benefits$7,547,333
Total Fundraising Expense$641,308
Grants and Similar Amounts Paid$501,347
Professional Fundraising Fees$36,000

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Fees for Services Other$6,458,003$204,798$19,124$6,681,925
Other Salaries and Wages$3,030,776$502,979$333,741$3,867,496
Current Officers, Directors, Trustees, and Key Employees$2,362,364$271,713$157,411$2,791,488
Information Technology$541,448$17,001$2,352$560,801
Occupancy$451,160$76,530$28$527,718
Office Expenses$202,778$164,157$13,307$380,242
Travel$343,973$28,239$1,941$374,153
Fees for Services Accounting-$347,569-$347,569
Payroll Taxes$270,050$39,882$25,190$335,122
Other Employee Benefits$260,160$38,297$26,097$324,554
Foreign Grants$265,464--$265,464
Grants to Domestic Orgs$235,883--$235,883
Pension Plan Contributions$185,645$27,541$15,487$228,673
Fees for Services Legal-$160,307-$160,307
Insurance$79,215$38,396$7,388$124,999
Depreciation Depletion$101,964$5,133$3,242$110,339
Fees for Services Lobbying$90,000--$90,000
Conferences and Meetings$81,051--$81,051
Fees for Services Professional Fundraising--$36,000$36,000
Total Functional Expenses$14,959,934$1,922,542$641,308$17,523,784

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$17,523,784
Total Expenses per Audited Statements$17,523,784
Total Expenses per Form 990$17,523,784
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Louisiana State University Health Sciences Center New OrleansNew Orleans, LA501(c)3Ptsd-aud Comorbidity Model Development$115,883
Texas a & MCollege Station, TX501(c)3Establishing Chronic Recording and Adapt Sps Fc and Er Procedures$100,000
CHILDREN'S HOSPITAL OF PHILADELPHIAPhiladephia, PA501(c)3Model of Individual Diff in Response Social Defeat in Rats$20,000

International Summary

Offices
0
Employees
0
Spending
$265,464

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
Europe (including Iceland & Greenland) - Albania, Andorra, Austria, BelgiumGrants to Recipients Located in RegionN/a00$265,464
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
Yes

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$36,000
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Deferred Rent$139,342
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“The board of directors reviewed and approved the form 990 prior to its filing. The form 990 was then authorized and signed by the organization's ceo & president.”

Form 990, Part VI, Section B, Line 12C

“The board of directors requires an annual declaration from all board members and senior management as to the existence and disclosure of any potential conflicts of interest. The board members sign a disclosure statement. Any potential conflicts are discussed by the dis-interested board members, while the party in potential conflict is required to leave the room. Board meeting minutes will document the discussion and decision making process. In the event of a potential conflict, procedures to obtain competitive bids and diligence on fair market value will be established.”

Form 990, Part VI, Section B, Line 15

“Cvb's executive compensation program is administered by the board of directors. The board is responsible for establishing and maintaining a competitive compensation program for the key executives of the organization. The board meets as needed to review the compensation program and make recommendations for any changes, as appropriate. A performance evaluation is conducted and reviewed each year and is intended to ensure that the compensation program falls within a reasonable range of competitive practices for comparable positions among similarly situated organizations. Following this review, the board reviews and approves, for selected key executives, base salaries and annual incentive opportunity adjustments, and objectives and goals upcoming year's annual incentive plan. The board reviews and recommends to the board salary approval and incentive awards for the ceo/president and selected key senior staff.”

Form 990, Part VI, Section C, Line 19

“Upon request and forms available through charity navigator website as well.”

Filing and Contact Details

Filer

Filer Name
Cohen Veterans Bioscience Inc
EIN
47-1981973
Phone
6469704325
Address
535 8TH AVENUE 12TH FLOOR, NEW YORK, NY 10018

Signing Officer

Name
Magali Haas Md Phd
Title
CEO & President
Phone
6469704325
Signed
2023-04-28
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Magali Haas Md Phd
Formed
2014
Legal Domicile
Ma
Voting Board Members
5
Independent Board Members
4
Employees
46
Volunteers
0

Preparer

Firm
Smith Sullivan & Brown Pc
Address
80 FLANDERS ROAD - SUITE 200, WESTBOROUGH, MA 01581
Preparer
Sandra M Brown CPA
Phone
5088717178
Supplemental Narrative

Additional Explanations

AMENDED RETURN EXPLANATION:

“Return amended to include all states recently registered with and filing form 990 in.”

Form 990, Part IX, Line 11G

“Other professional fees: program service expenses 195,205. Management and general expenses 204,798. Fundraising expenses 0. Total expenses 400,003. Research collaboration expenses: program service expenses 2,431,734. Management and general expenses 0. Fundraising expenses 0. Total expenses 2,431,734. Contracted services: program service expenses 3,831,064. Management and general expenses 0. Fundraising expenses 19,124. Total expenses 3,850,188.”

FORM 990, PART XI, LINE 9:

“Change in future grant obligations 202,850.”

Financial Statement Notes

PART X, LINE 2:

“Tax position: the organization currently evaluates all tax positions, and makes a determination regarding the likelihood of those positions being upheld under review. The primary tax position made by the organization is the existence of unrelated business income tax and the organization's status as a tax-exempt organization under section 501(c)(3) of the internal revenue code. For the year presented, the organization has not recognized any tax benefits or loss contingencies for uncertain tax positions based on this evaluation.”

Raw XML AppendixShowing 400 of 972 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt02078653
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt02682753
IRS990/AccountsReceivableGrp/EOYAmt021300
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0BIOMEDICAL RESEARCH AND TECHNOLOGY ORGANIZATION DEDICATED TO ADVANCING BRAIN HEALTH BY FAST-TRACKING PRECISION DIAGNOSTICS AND TAILORED THERAPEUTICS.
IRS990/AddressChangeInd0X
IRS990/AllOtherContributionsAmt017856836
IRS990/AmendedReturnInd0X
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0GELMAN ROSENBERG AND FREEDMAN CPA
IRS990/BooksInCareOfDetail/PhoneNum03019519090
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt04550 MONTGOMERY AVENUE SUITE 650N
IRS990/BooksInCareOfDetail/USAddress/CityNm0BETHESDA
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MD
IRS990/BooksInCareOfDetail/USAddress/ZIPCd020814
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt0654129
IRS990/CashNonInterestBearingGrp/EOYAmt0999648
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt015
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt0157411
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt0271713
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt02362364
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt02791488
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt081051
IRS990/ConferencesMeetingsGrp/TotalAmt081051
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContractorCompensationGrp/CompensationAmt0861974
IRS990/ContractorCompensationGrp/CompensationAmt1701210
IRS990/ContractorCompensationGrp/CompensationAmt2321233
IRS990/ContractorCompensationGrp/CompensationAmt3273913
IRS990/ContractorCompensationGrp/CompensationAmt4239234
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/AddressLine1Txt04550 MONTGOMERY AVENUE SUITE 800
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CityNm0NORTH BETHESDA
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CountryCd0UK
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/ForeignPostalCd020814
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt02535 AUGUSTINE DRIVE
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt110161 WEST RUN PARK DRIVE SUITE 15
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt21701 MARKET STREET
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt363 PUTNAM STREET SUITE 202
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0SANTA CLARA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm1LAS VEGAS
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm2PHILADELPHIA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm3SARASOTA SPRINGS
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0CA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd1NV
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd2PA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd3NY
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd0950543003
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd189145
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd219103
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd312866
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0HITACHI VANTARA LLC
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt1WAVEACCESS USA
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt2GRF CPA'S & ADVISORS
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt3MORGAN LEWIS AND BOCKIUS LLP
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt4TONE CREATIVE LLC
IRS990/ContractorCompensationGrp/ServicesDesc0CLOUD-BASED ARCHITECTURE BUILD AND MANAG
IRS990/ContractorCompensationGrp/ServicesDesc1RESOURCES FOR BRAIN COMMONS AND EARLY SI
IRS990/ContractorCompensationGrp/ServicesDesc2ACCOUNTING AND BOOKKEEPING
IRS990/ContractorCompensationGrp/ServicesDesc3LEGAL SERVICES
IRS990/ContractorCompensationGrp/ServicesDesc4MARKETING AND DESIGN SERVICES
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt017941055
IRS990/CYGrantsAndSimilarPaidAmt0501347
IRS990/CYInvestmentIncomeAmt028608
IRS990/CYOtherExpensesAmt09439104
IRS990/CYOtherRevenueAmt0112735
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0558614
IRS990/CYSalariesCompEmpBnftPaidAmt07547333
IRS990/CYTotalExpensesAmt017523784
IRS990/CYTotalFundraisingExpenseAmt0641308
IRS990/CYTotalProfFndrsngExpnsAmt036000
IRS990/CYTotalRevenueAmt018082398
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/FundraisingAmt03242
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt05133
IRS990/DepreciationDepletionGrp/ProgramServicesAmt0101964
IRS990/DepreciationDepletionGrp/TotalAmt0110339
IRS990/Desc0BRAIN HEALTH TOOLS & TECHNOLOGIES:IN ORDER TO FAST-TRACK PRECISION DIAGNOSTICS AND TARGETED THERAPEUTICS AND WELLNESS APPROACHES FOR MAINTENANCE AND RESTORATION OF BRAIN HEALTH, CVB IS LEVERAGING INNOVATION AND TECHNOLOGY TO BUILD TOOLS AND PLATFORMS THAT ENABLE DISCOVERY AND DEVELOPMENT ACROSS BRAIN DISEASES. THESE TOOLS & PLATFORMS ALLOW RESEARCHERS FROM ACADEMIA AND INDUSTRY TO ACCESS AND UTILIZE BEST-IN-CLASS PRACTICES AND ALLOW EFFORTS TO BE SCALED WITH RIGOR AND REPRODUCIBILITY.(SEE SCHEDULE O FOR FULL DETAIL OF OUR PROGRAMS)PLATFORM EFFORTS FOCUS ON CAPACITY THAT ENABLES RELIABLE DISCOVERY OF BIOMARKERS AND BIOLOGICAL PATHWAYS THAT ARE TRANSLATIONALLY RELEVANT FOR THE DEVELOPMENT OF DIAGNOSTICS AND THERAPEUTIC TARGETS FOR DRUG AND OTHER MEDICAL INTERVENTIONS. EACH PLATFORM IS CREATING RESEARCH TOOLS (E.G. ANIMAL MODELS, DATA STANDARDS, COMPUTATIONAL MODELS, REFERENCE DATABASES, ETC.) THAT WILL ACCELERATE/FOSTER THESE DISCOVERIES.WITHIN THIS FRAMEWORK, CVB HAS ESTABLISHED BOTH INTRAMURAL (RESEARCH CONDUCTED BY, OR INCLUDING, CVB STAFF OR CONTRACTORS) AND EXTRAMURAL RESEARCH PROGRAMS (RESEARCH CONDUCTED VIA GRANTS OR IN COLLABORATION WITH EXTERNAL ACADEMIC, INDUSTRY, FOUNDATION AND GOVERNMENT PARTNERS) AND ALSO OPERATES SEVERAL PUBLIC-PRIVATE PARTNERSHIPS. THESE COOPERATIVE ALLIANCES ORGANIZE AND FUND A NETWORK OF PARTNERS WHO EACH CONTRIBUTE COMPLEMENTARY AND SYNERGISTIC DATA, CAPABILITIES, OR EXPERTISE TO SUPPORT A COMMON ROADMAP FOR IDENTIFYING DIAGNOSTIC BIOMARKERS, BUILDING PREDICTIVE BRAIN DISEASE MODELS, DEVELOPING ROBUST STANDARDIZED TRANSLATIONAL TOOLS, AND CATALYZING PHARMACEUTICAL DRUG DEVELOPMENT. THE EMPHASIS IS ON TEAM SCIENCE WITH COHEN VETERANS BIOSCIENCE SERVING AS ITS HUB.OUR PLATFORM PROGRAMS CURRENTLY INCLUDE THE BRAINCOMMONS (CLOUD-BASED DATA & ANALYTICS), EARLYSIGNAL (WEARABLE AND HOME SENSORS FOR MONITORING HEALTH STATUS), RAPID-DX (ESTABLISHING BEST PRACTICES FOR DISCOVERY AND VALIDATION OF BIOMARKERS) AND AMP-IT-UP (FOR PRECLINICAL DISCOVERY AND TRANSLATION).BRAINCOMMONS:WE ARE IN A NEW ERA OF BRAIN RESEARCH, WHERE POWERFUL DATA ACQUISITION TECHNOLOGIES ARE GENERATING MULTIMODAL DATA AT INCREASING SCALES. OUR PRIMARY CHALLENGE TODAY EXTENDS BEYOND DATA GENERATION; RATHER, IT LIES IN DATA UTILIZATION AND KNOWLEDGE EXTRACTION. TO ENABLE DISEASE MODELING EFFORTS, AS WELL AS THE DISCOVERY AND REPLICATION OF BIOMARKERS, THERE IS A CRITICAL NEED FOR A PLATFORM THAT CAN HOUSE MULTI-MODAL DATA TYPES, ACROSS DIAGNOSTIC CATEGORIES, IN CONJUNCTION WITH DATA PIPELINES TO ENSURE REPRODUCIBLE ANALYSIS, AND WITH AN ABILITY TO APPLY STATE-OF-THE ART MACHINE-LEARNING ALGORITHMS. THE BRAINCOMMONS AIMS TO DELIVER ON THIS POTENTIAL, AS THE FIRST BIG-DATA CLOUD-BASED PLATFORM FOR COMPUTATIONAL INNOVATION DISCOVERY IN BRAIN DISEASES THAT SUPPORTS RAW DATA INTEGRATION, INTEROPERABILITY BETWEEN SYSTEMS AND A DATA MODEL THAT OFFERS A COMPATIBLE FORMAT ADHERING TO COMMON STANDARDS WHERE ALL THE DATA, NO MATTER THE SIZE OR TYPE, CAN BE COMBINED FOR RE-USE, FUELING DISCOVERY AND COLLABORATION ACROSS THE MULTIDISCIPLINARY AND MULTI-SECTOR RESEARCH COMMUNITY, AND DRIVING DIAGNOSTIC AND THERAPEUTIC INNOVATION TO REDUCE THE BURDEN OF BRAIN-BASED DISORDERS.IN 2022, THE BRAINCOMMONS WAS LAUNCHED TO OUR FIRST COMMUNITY OF RESEARCH PARTNERS IN PTSD, TBI AND PARKINSON'S.EARLYSIGNAL:WEARABLE AND SENSOR TECHNOLOGIES HOLD PROMISE IN THE ASSESSMENT AND CONTINUOUS MONITORING OF PATIENTS IN ORDER TO BETTER SCREEN AND DIAGNOSE, MONITOR DISEASE PROGRESSION, AND OBSERVE INTERVENTION RESPONSE OR LACK THEREOF. DIGITAL HEALTH MONITORING ALSO ALLOWS US TO STUDY BRAIN HEALTH AND DISEASE IN UNPRECEDENTED WAYS, BY TRACKING VARIABLES SUCH AS SLEEP, PHYSICAL ACTIVITY, STRESS AND COGNITION, WE MAY BE ABLE TO BETTER UNDERSTAND WHAT CHANGES OVER TIME - AND TO DEVELOP EARLIER AND PREVENTIVE DIAGNOSTICS AND TREATMENTS TO MAKE A DIFFERENCE IN PATIENTS' LIVES. MEDICAL-GRADE DATA IS NEEDED FOR FDA APPROVAL OF SUCH PLATFORMS FOR USE IN MEDICAL DECISION MAKING
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd01
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt07705967
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt04630335
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt046
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt014959934
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt0347569
IRS990/FeesForServicesAccountingGrp/TotalAmt0347569
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt0160307
IRS990/FeesForServicesLegalGrp/TotalAmt0160307
IRS990/FeesForServicesLobbyingGrp/ProgramServicesAmt090000
IRS990/FeesForServicesLobbyingGrp/TotalAmt090000
IRS990/FeesForServicesOtherGrp/FundraisingAmt019124
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt0204798
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt06458003
IRS990/FeesForServicesOtherGrp/TotalAmt06681925
IRS990/FeesForServicesProfFundraising/FundraisingAmt036000
IRS990/FeesForServicesProfFundraising/TotalAmt036000
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt0265464
IRS990/ForeignGrantsGrp/TotalAmt0265464
IRS990/ForeignOfficeInd01
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt060.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt19.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt640.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt740.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt840.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt940.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1140.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1240.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1340.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1440.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1540.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt025999
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt631076
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt795841
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt838412
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt948736
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1055935
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1151937
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1225589
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1343678
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1429396
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1529572
IRS990/Form990PartVIISectionAGrp/PersonNm0MAGALI HAAS MD PHD
IRS990/Form990PartVIISectionAGrp/PersonNm1THERESA FRANGIOSA
IRS990/Form990PartVIISectionAGrp/PersonNm2MICHAEL SULLIVAN
IRS990/Form990PartVIISectionAGrp/PersonNm3DAVID BIONDI
IRS990/Form990PartVIISectionAGrp/PersonNm4DOUGLAS HAYNES
IRS990/Form990PartVIISectionAGrp/PersonNm5DAVE DEMARCO
IRS990/Form990PartVIISectionAGrp/PersonNm6ANDREAS JEROMIN PHD
IRS990/Form990PartVIISectionAGrp/PersonNm7LEE LANCASHIRE
IRS990/Form990PartVIISectionAGrp/PersonNm8ALLYSON GAGE PHD
IRS990/Form990PartVIISectionAGrp/PersonNm9AMANDA NICOLE HARMON
IRS990/Form990PartVIISectionAGrp/PersonNm10EVGENY RAKHMATULIN
IRS990/Form990PartVIISectionAGrp/PersonNm11KERSTEN SMALL
IRS990/Form990PartVIISectionAGrp/PersonNm12LAUREN GOLDSMITH
IRS990/Form990PartVIISectionAGrp/PersonNm13MARK ZERVAS
IRS990/Form990PartVIISectionAGrp/PersonNm14MARYAN ZIRKLE
IRS990/Form990PartVIISectionAGrp/PersonNm15RENEE DAVIS
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0630807
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt6433741
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt7340407
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt8492702
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt9282489
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10323355
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt11260970
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt12217861
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt13177660
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt14280815
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt15282286
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt150
IRS990/Form990PartVIISectionAGrp/TitleTxt0CEO & PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt2TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt3BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt4FORMER BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt5BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt6CHIEF SCIENTIFIC OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt7CHIEF INFORMATION OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt8CHIEF MEDICAL OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt9CHIEF OPERATIONS OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt10CHIEF TECHNOLOGY OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt11DEPUTY DIRECTOR, TRANSLATIONAL RND
IRS990/Form990PartVIISectionAGrp/TitleTxt12SENIOR DIRECTOR, CONTRACTS
IRS990/Form990PartVIISectionAGrp/TitleTxt13DEPUTY DIRECTOR, TRANSLATIONAL SCIENCE
IRS990/Form990PartVIISectionAGrp/TitleTxt14EXECUTIVE DIRECTOR, BRAINCOMMONS
IRS990/Form990PartVIISectionAGrp/TitleTxt15EXECUTIVE DIRECTOR, DEVELOPMENT
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02014
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt05
IRS990/GovernmentGrantsAmt084219
IRS990/GrantAmt0501347
IRS990/GrantsPayableGrp/BOYAmt04606870
IRS990/GrantsPayableGrp/EOYAmt0877731
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0235883
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0235883
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt018082398
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt04
IRS990/IndivRcvdGreaterThan100KCnt020
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt02352
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt017001
IRS990/InformationTechnologyGrp/ProgramServicesAmt0541448
IRS990/InformationTechnologyGrp/TotalAmt0560801
IRS990/InsuranceGrp/FundraisingAmt07388
IRS990/InsuranceGrp/ManagementAndGeneralAmt038396
IRS990/InsuranceGrp/ProgramServicesAmt079215
IRS990/InsuranceGrp/TotalAmt0124999
IRS990/InvestmentIncomeGrp/ExclusionAmt028608
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt028608
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt045
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt0196040
IRS990/LandBldgEquipBasisNetGrp/BOYAmt0234254
IRS990/LandBldgEquipBasisNetGrp/EOYAmt01432920
IRS990/LandBldgEquipCostOrOtherBssAmt01628960
IRS990/LegalDomicileStateCd0MA
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd01
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0COHEN VETERANS BIOSCIENCE, INC. IS A NON-PROFIT 501(C)(3) BIOMEDICAL RESEARCH AND TECHNOLOGY ORGANIZATION DEDICATED TO ADVANCING BRAIN HEALTH BY FAST-TRACKING PRECISION DIAGNOSTICS AND TAILORED THERAPEUTICS.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt011126061
IRS990/NetAssetsOrFundBalancesEOYAmt011887525
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt03420094
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt07257190
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/FundraisingAmt028
IRS990/OccupancyGrp/ManagementAndGeneralAmt076530
IRS990/OccupancyGrp/ProgramServicesAmt0451160
IRS990/OccupancyGrp/TotalAmt0527718
IRS990/OfficeExpensesGrp/FundraisingAmt013307
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0164157
IRS990/OfficeExpensesGrp/ProgramServicesAmt0202778
IRS990/OfficeExpensesGrp/TotalAmt0380242
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt0534269
IRS990/OtherAssetsTotalGrp/EOYAmt0883589
IRS990/OtherChangesInNetAssetsAmt0202850
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt026097
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt038297
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt0260160
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0324554
IRS990/OtherLiabilitiesGrp/BOYAmt0141000
IRS990/OtherLiabilitiesGrp/EOYAmt0139342
IRS990/OtherRevenueMiscGrp/BusinessCd0900099
IRS990/OtherRevenueMiscGrp/BusinessCd1900099
IRS990/OtherRevenueMiscGrp/Desc0OTHER REFUNDS
IRS990/OtherRevenueMiscGrp/Desc1STIMULUS/COVID CREDITS
IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt0110255
IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt12480
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt0110255
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt12480
IRS990/OtherRevenueTotalAmt0112735
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt0333741
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0502979
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt03030776
IRS990/OtherSalariesAndWagesGrp/TotalAmt03867496
IRS990/OtherWebsiteInd0X
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/FundraisingAmt025190
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt039882
IRS990/PayrollTaxesGrp/ProgramServicesAmt0270050
IRS990/PayrollTaxesGrp/TotalAmt0335122
IRS990/PensionPlanContributionsGrp/FundraisingAmt015487
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt027541
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt0185645
IRS990/PensionPlanContributionsGrp/TotalAmt0228673
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt04776718
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt08295108
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt0268785
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt0123073
IRS990/PrincipalOfficerNm0MAGALI HAAS MD PHD
IRS990/ProfessionalFundraisingInd01
IRS990/ProgSrvcAccomActy2Grp/Desc0THE INAUGURAL STATE OF THE SCIENCE SUMMIT ("SOSS"), HELD IN 2018, FOCUSED ON DIAGNOSIS OF TRAUMA-RELATED BRAIN DISORDERS WITH A MAJOR FOCUS ON POST-TRAUMATIC STRESS DISORDER. THE TRAUMA-RELATED BRAIN DISORDERS RESEARCH COMMUNITY HAS IDENTIFIED A NEED TO ESTABLISH A MECHANISM-BASED TAXONOMY FOR THESE CONDITIONS TO ADVANCE BIOMARKER DISCOVERY AS WELL AS DIAGNOSIS AND THERAPEUTIC DEVELOPMENT. A SHIFT FROM A SYNDROMIC CLASSIFICATION SYSTEM TO A MECHANISTIC ONE NECESSITATES A REVIEW OF THE CURRENT SCIENTIFIC KNOWLEDGE, ADOPTION OF NEW SCIENTIFIC MODELS, AND IDENTIFICATION OF RESEARCH AND KNOWLEDGE GAPS. THE SOSS BROUGHT TOGETHER MULTIDISCIPLINARY STAKEHOLDERS WITH DEEP SCIENTIFIC AND CLINICAL EXPERTISE TO ADDRESS THIS PRESSING NEED.THE THEME OF THE SECOND STATE OF THE SCIENCE SUMMIT, HELD IN 2019 WAS PATHS TO TREATMENT FOR TRAUMATIC BRAIN INJURY(S) WITH A FOCUS ON THE TAXONOMY AND NOSOLOGY OF THE CHRONIC SEQUELAE, CHALLENGES AND OPPORTUNITIES IN CLINICAL PRACTICE AND DEVELOPMENT, AND ETIOLOGY AND MECHANISM OF PERSISTENT SYMPTOMS. AS MEASUREMENT TOOLS ADVANCE, RESEARCH HAS BEEN ABLE TO FOCUS ON DIFFERENT TYPES OF INJURY, BEYOND THE MILD, MODERATE, AND SEVERE CLASSIFICATIONS OF TBI. TO AUGMENT AND SUPPORT THE MANY EFFORTS ACROSS FIELDS AND ORGANIZATIONS OVER THE PAST DECADE, IN 2020 WE WORKED WITH THOUGHT LEADERS ACROSS TBI TO PREPARE A CONSENSUS BLUEPRINT TO DRIVE TRANSLATIONAL SCIENCE FOR TBI. IN 2021, WE PUBLISHED SIX CONSENSUS ARTICLES FROM THE TBI SUMMIT IN THE JOURNAL OF NEUROTRAUMA OUTLINING GAPS AND RECOMMENDATIONS FOR FUTURE RESEARCH.IN 2022, WE HELD THE FIRST BRAIN TRAUMA ACTION SUMMIT, TO PLAN TO EXECUTE THE TBI PRECISION RESEARCH ROADMAP, THROUGH COLLECTIVE PUBLIC AND PRIVATE ACTION.BEST BIOMARKER PTSD STUDY:DESPITE THE EFFICACY OF PSYCHOTHERAPY AS FIRST-LINE TREATMENT FOR PTSD, LARGE INTER-INDIVIDUAL DIFFERENCES IN OUTCOMES EXIST, WITH ROUGHLY 50% OF PATIENTS RESPONDING TO TREATMENT AND FEWER THAN THAT FULLY REMITTING. THIS GRANT SUPPORTED THE DEVELOPMENT OF A RESPONSE DIAGNOSTIC TEST BASED ON PRELIMINARY FINDINGS FOR A COMBINATION COGNITIVE/IMAGING MARKER RESULTING FROM CVB'S INVESTMENT IN THE COHEN VETERANS CENTER STUDY AT NYU/STANFORD. THE PROGRAM INCLUDED A CLINICAL STUDY AT TWO CENTERS OF OVER 200 SUBJECTS TO REPLICATE THE INITIAL FINDING, AND IS SEEKING QUALIFICATION VIA THE FOOD AND DRUG ADMINISTRATION ("FDA") GUIDANCE TO SUPPORT THE COMMERCIALIZATION AND/OR AVAILABILITY OF THE TEST FOR CLINICAL PRACTICE AND RESEARCH AND DEVELOPMENT. THIS STUDY COMPLETED RECRUITMENT IN DECEMBER 2019 AND SEMINAL RESULTS WHICH DEMONSTRATE THAT AN EEG BASED BIOMARKER CAN PREDICT TREATMENT RESPONSE FOR INDIVIDUALS WITH PTSD OR MDD WERE PUBLISHED IN 2020 AND 2021.IN 2022, WE CONDUCTED BIOMARKER ASSAYS ON BLOOD SAMPLES COLLECTED IN THE BEST STUDY PROGRAM TO LOOK FOR GENETIC AND INFLAMMATORY MARKERS THAT MAY BE PREDICTIVE OF RESPONSE AND/OR DISEASE.PTSD GENETICS PROGRAM:THE PSYCHIATRIC GENETICS CONSORTIUM-PTSD WORKING GROUP - BROAD INSTITUTE COLLABORATION IS SUPPORTING THE LARGEST GLOBAL GENOME WIDE ASSOCIATION STUDY ("GWAS") OF PTSD TO DATE WITH DATA FROM OVER 200,000 INDIVIDUALS ANALYZED. THE MAIN GOAL IS TO UNCOVER THE GENETIC UNDERPINNINGS OF PTSD RISK AND PUBLISH ALL RESULTS. SEMINAL FINDINGS OF THE FIRST PTSD GENETIC RISK LOCI FROM THIS PROGRAM WERE PUBLISHED IN NATURE COMMUNICATIONS IN OCTOBER 2019.IN 2022, THE GWAS PROGRAM HAS EXPANDED TO INCLUDE OVER 350,000 INDIVIDUALS WITH TRAUMA AND 2 MILLION HEALTH CONTROLS YIELDING >77 IDENTIFIED GENETIC RISK LOCI.PRISM2 (PSYCHIATRIC RATINGS USING INTERMEDIATE STRATIFIED MARKERS 2):IN 2021, WE JOINED THE INNOVATIVE MEDICINES INITIATIVE AND EUROPEAN FEDERATION OF PHARMACEUTICAL INDUSTRIES AND ASSOCIATIONS (EFPIA) AS A FUNDER AND COLLABORATOR IN THE PRISM2 STUDY PROGRAM. BUILDING ON THE SUCCESS OF INNOVATIVE RESEARCH BY THE PRISM PROJECT, THE INNOVATIVE MEDICINE INITIATIVE 2, A JOINT UNDERTAKING BETWEEN THE EU AND THE EUROPEAN FEDERATION OF PHARMACEUTICAL INDUSTRIES AND ASSOCIATIONS (EFPIA),
IRS990/ProgSrvcAccomActy3Grp/Desc0MULTIPLE SCLEROSIS ("MS") 1.0:THE ORION BIONETWORKS FLAGSHIP PROGRAM SUCCESSFULLY PILOTED THE ESTABLISHMENT OF A MULTIPLE SCLEROSIS BIONETWORK COMPRISED OF ACADEMIC (NEUROSCIENCE INSTITUTE OF THE BRIGHAM AND WOMEN'S HOSPITAL), ADVOCACY (ACCELERATED CURE PROJECT FOR MS), COMPUTATIONAL (GNS HEALTHCARE, METACELL, THOMSON REUTERS), INFORMATICS (CONVERGE BY DELOITTE, RANCHO BIOSCIENCES, EXAPTIVE), AND ONLINE PATIENT COMMUNITY PARTNERS (PATIENTSLIKEME [PLM]). DE-IDENTIFIED HIPPA-COMPLIANT DATA FROM THREE DATABASES WERE CURATED AND LOADED INTO A CLOUD-BASED DATA KNOWLEDGE MANAGEMENT SYSTEM. THE INTEGRATED REPOSITORY INCLUDES 9,000 SUBJECTS WITH MS AND RELATED CONDITIONS. THE ALLIANCE DEVELOPED A ROADMAP FOR JOINT EXECUTION WITH SPECIFIC SCIENTIFIC AIMS. THE ALLIANCE HAS GENERATED MULTIPLE MODELS BASED ON THE DATA REPOSITORY USING DIFFERENT ALGORITHMIC APPROACHES: PHENOTYPIC PROGNOSTIC MODEL AND TWO MOLECULAR PROGNOSTIC MODELS.PTSD AND TBI PRECLINICAL MODELING PROGRAM:ANIMAL MODELS OF PSYCHIATRIC DISORDERS OFFER A COMPLEMENTARY RESEARCH MODALITY THAT SUPPORTS CLINICAL RESEARCH. IN ORDER TO ACHIEVE A SATISFACTORY DEGREE OF VALIDITY AND RELIABILITY, ANIMAL MODELS OF COMPLEX AND INTRICATE PSYCHIATRIC DISORDERS, SUCH AS PTSD, MUST FULFILL CERTAIN CRITERIA: PATHOGENIC PROCESSES MUST BE OBSERVABLE AND MEASURABLE, AND MUST RELIABLY REFLECT CLINICAL SYMPTOMATOLOGY, AND PHARMACOLOGICAL AGENTS THAT ARE KNOWN TO AFFECT SYMPTOMS IN HUMAN SUBJECTS, SHOULD MODULATE THESE PROCESSES. CVB HAS ESTABLISHED THE ALLIANCE FOR MODELS OF PTSD, INNOVATIVE TECHNOLOGIES AND UNIFORM PRACTICES ("AMP-IT- UP") TO SUPPORT PRECLINICAL MODEL DEVELOPMENT. MULTIPLE SUB-GRANT AWARDS COMPLETED AND PUBLISHED THEIR FINDING THIS YEAR IN SUPPORT THE MISSION OF THIS PROGRAM.PEERS - THE PLATFORM FOR THE EXCHANGE OF EXPERIMENTAL RESEARCH STANDARDSPEERS IS A PLATFORM THAT ENABLES SHARING OF INFORMATION ON PARAMETERS THAT AFFECT THE ROBUSTNESS OF PRECLINICAL DATA. PEERS IS LIKE A WIKI ON HOW TO DESIGN, CONDUCT AND ANALYZE EXPERIMENTS TO INCREASE DATA ROBUSTNESS. PEERS ALLOWS USERS TO SEARCH FOR FACTORS AND PARAMETERS THAT ARE OF RELEVANCE TO THEIR EXPERIMENTS AND GIVES GUIDANCE AND ADVICE ON HOW TO LEVERAGE THESE FACTORS TO INCREASE THE QUALITY, ROBUSTNESS AND REPRODUCIBILITY OF RESEARCH. PEERS ALLOWS USERS TO: (1) SEARCH FOR FACTORS AND PARAMETERS THAT ARE OF RELEVANCE TO THEIR EXPERIMENTS (2) FIND RECOMMENDATIONS AND BEST PRACTICES ON EXPERIMENTAL DESIGN, EXECUTION AND DATA ANALYSIS FOR SPECIFIC IN VITRO METHODS OR IN VIVO MODELS (3) SHARE EXPERIENCES AND KNOWLEDGE TO HELP OTHERS BUILD HIGH-QUALITY, REPRODUCIBLE DATA SETS (4) CITE CONTRIBUTIONS (5) INCREASE THE QUALITY, ROBUSTNESS AND REPRODUCIBILITY OF RESEARCH.ADDRESSING SEX AS A BIOLOGICAL VARIABLE IN PRECLINICAL RESEARCH:DIFFERENCES BETWEEN MALES AND FEMALES EXTEND WELL BEYOND REPRODUCTION, WITH SIGNIFICANT IMPLICATIONS FOR HUMAN HEALTH AND DISEASE. THIS IS PARTICULARLY THE CASE IN THE FIELD OF NEUROSCIENCE, WHERE DIFFERENCES IN BASIC BIOLOGY BETWEEN MEN AND WOMEN CAN LEAD TO SEX DIFFERENCES IN THE PREVALENCE, PROGRESSION, AND RESPONSES TO TREATMENT OF MANY BRAIN DISORDERS.THIS VIDEO TRAINING SERIES WAS DEVELOPED AND LAUNCHED BY COHEN VETERANS BIOSCIENCE IN 2022, TO ENSURE THAT EARLY-STAGE RESEARCH IS CONDUCTED TO THE HIGHEST AND MOST RIGOROUS STANDARDS POSSIBLE. ONE SOLUTION IS TO ENSURE THAT THE RESEARCH COMMUNITY-INCLUDING GRADUATE STUDENTS, POSTDOCS, AND OTHER EARLY CAREER RESEARCHERS-HAVE THE TOOLS THEY NEED TO ENABLE THE IMPLEMENTATION OF BEST PRACTICES ACROSS THE EXPERIMENTAL PROCESS. THE GOAL OF THE VIDEO TRAINING SERIES, WHICH CONTAINS THREE MODULES, WAS TO PROVIDE PRACTICAL GUIDANCE TO PRECLINICAL RESEARCHERS ON HOW TO NAVIGATE THE NIH'S 2015 POLICY ON INCORPORATING SEX AS A BIOLOGICAL VARIABLE INTO THEIR CURRENT AND FUTURE RESEARCH.GLOBAL PRECLINICAL DATA FORUM:THE GLOBAL PRECLINICAL DATA FORUM ("GPDF") IS A JOINTLY SPONSORED U.S. AND EUROPEAN INITIATIVE THAT ENCOURAGES GLOBAL COLLABORATION TO ADDRESS THE CHALLENG
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt016160581
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0235660
IRS990/PYInvestmentIncomeAmt059585
IRS990/PYOtherExpensesAmt09371369
IRS990/PYOtherRevenueAmt032104
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-1858150
IRS990/PYSalariesCompEmpBnftPaidAmt08452791
IRS990/PYTotalExpensesAmt018110420
IRS990/PYTotalProfFndrsngExpnsAmt050600
IRS990/PYTotalRevenueAmt016252270
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0558614
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd01
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt011484429
IRS990/SavingsAndTempCashInvstGrp/EOYAmt03831713
IRS990ScheduleA/FactsAndCircumstancesTestTxt0COHEN VETERANS BIOSCIENCE, INC. ("CVB") IS A PUBLIC CHARITY BIOMEDICAL RESEARCH AND TECHNOLOGY ORGANIZATION DEDICATED TO ADVANCING BRAIN HEALTH BY FAST-TRACKING PRECISION DIAGNOSTICS AND TAILORED THERAPEUTICS. WE ARE LEADING THE WAY TO CURE INVISIBLE WOUNDS FOR THE MILLIONS OF VETERANS, SERVICE MEMBERS, FIRST RESPONDERS, AND CIVILIANS WHO SUFFER FROM TRAUMA-RELATED CONDITIONS, SUCH AS PTSD, TBI AND SUICIDE. GLOBALLY, 2 BILLION INDIVIDUALS ARE DIRECTLY AFFECTED BY BRAIN DISORDERS. THE WORLD HEALTH ORGANIZATION ATTRIBUTES 38% OF THE TOTAL YEARS LOST TO DEATH AND DISABILITY TO BRAIN DISORDERS, A FIGURE WELL AHEAD OF THE NEXT-CLOSEST AND HIGHER-PROFILE DISEASES OF CANCER (12.7%) AND CARDIOVASCULAR DISEASE (11.8%). CVB IS CATALYZING RESEARCH TO ADVANCE BRAIN HEALTH AT ALL STAGES OF SCIENTIFIC DISCOVERY-FROM THEORY TO THERAPEUTIC.THIS MEMO PROVIDES EVIDENCE OF QUANTITATIVE AND QUALITATIVE MEASURES WHICH SUPPORT CONTINUED PUBLIC CHARITY STATUS. CVB MET THE QUANTITATIVE PERCENTAGE TEST CRITERION FOR SUPPORTING FACTS AND CIRCUMSTANCES IN FY21. CVB ENGAGES WITH AND MAKES AVAILABLE TO RESEARCHERS, POLICY MAKERS, AND THE GENERAL PUBLIC A BROAD ARRAY OF PROGRAMS, TOOLS, SERVICES, AND INFORMATION WHICH ADVANCE THE STATE OF BRAIN SCIENCE, GUIDED BY AN INDEPENDENT BOARD AND ADVISORY COUNSELS IN CONJUNCTION WITH CVB'S RENOWNED EXPERTS IN RELEVANT FIELDS OF NEUROSCIENCE, DATA SCIENCE AND PHARMACEUTICAL RESEARCH AND DEVELOPMENT. FOLLOWING ARE MORE DETAILED EVIDENCE OF THESE FACTS AND CIRCUMSTANCES. COHEN VETERANS BIOSCIENCE, INC. EARLY ORIGINS WERE AS AN ORGANIZATION UNDER THE FISCAL SPONSORSHIP OF THE MARIN COUNTY COMMUNITY FOUNDATION, LATER ESTABLISHED AS A STAND-ALONE 501(C)3 IN 2014 UNDER THE NAME ORION BIONETWORKS. CVB'S FOUNDER AND CEO HAS A PERSONAL CONNECTION TO THE PUBLIC WORK THE ORGANIZATION CARRIES OUT BY VIRTUE OF HER HUSBAND BEING A VETERAN OF THE US AIRFORCE SERVICE AND HER SISTER SERVING AS AN AIRFORCE COLONEL, WITH ACTIVE DEPLOYMENTS TO OEF/OIF. THE FORMAL NAME CHANGE TO COHEN VETERANS BIOSCIENCE TOOK PLACE IN 2015 IN CONCERT WITH GENEROUS SEED FUNDING FROM STEVEN A. COHEN. CVB QUALIFIES AS A PUBLIC CHARITY UNDER THE "FACTS AND CIRCUMSTANCES" TEST OF 1.170A-9(F)(3) OF THE TREASURY REGULATIONS, BASED UPON THE FOLLOWING:CVB IS ORGANIZED AND OPERATED SO AS TO ATTRACT NEW AND ADDITIONAL FUNDING ON A CONTINUOUS AND BONA FIDE BASIS; CVB HAS HAD A DONATION BUTTON ON ITS WEBSITE AND ALL SOCIAL MEDIA SINCE INCEPTION. AS OF FY22, WE HAVE ESTABLISHED REGISTERED STATUS ACROSS ALL 50 STATES. THE ORGANIZATION RUNS SEVERAL ONLINE DONATION CAMPAIGNS THROUGHOUT THE YEAR (E.G. MEMORIAL DAY, VETERENS DAY, GIVING DAY). IN FY22 WE HAVE AUGMENTED THIS WITH THE ESTABLISHMENT OF AN AMBASSADOR'S PROGRAM WHICH PROVIDES A "CROWDSOURCED" APPROACH WHERE INDIVIDUALS AND OTHER NONPROFIT INSTITUTIONS RAISE DONATIONS TO SUPPORT OUR MISSION. WE HAVE ALSO EXPANDED OUR CONDUCT OF FUNDRAISING EVENTS AT MAJOR EVENTS, E.G. COLFAX MARATHON IN DENVER. THE ORGANIZATION HAS ACTIVELY PURSUED AND RECEIVED GRANTS FROM GOVERNMENT AND PUBLIC CHARITIES AND FOUNDATIONS FOCUSED ON BRAIN DISEASES. IN CVB'S EARLY YEARS OF EXISTENCE THE SCOPE OF ITS SOLICITATION WAS MORE LIMITED TO PERSONS DEEMED MOST LIKELY TO PROVIDE EARLY FUNDING IN AN AMOUNT SUFFICIENT TO ENABLE IT TO COMMENCE ITS CHARITABLE ACTIVITIES AND EXPAND THE SOLICITATION PROGRAM. DIRECT OUTREACH TO POTENTIAL SUPPORTERS IS INCREASINGLY CONDUCTED BY CVB'S CEO AND OTHER EXECUTIVE TEAM AND SCIENTIFIC STAFF. CVB NOW REGULARLY CONDUCTS BROAD OUTREACH CAMPAIGNS, HAS STAFF DEDICATED TO FUNDRAISING AND SUPPORTER ENGAGEMENT TO SOLICIT CHARITABLE CONTRIBUTIONS FROM THE GENERAL PUBLIC, AND CARRIES ON ACTIVITIES DESIGNED TO ATTRACT SUPPORT FROM GOVERNMENT SOURCES AND PUBLIC CHARITIES. IN 2022, WE LAUNCHED AN ANNUAL MEMBERSHIP PROGRAM WITH OTHER NONPROFIT FOUNDATIONS, UNDER OUR COALITION TO HEAL INVISIBLE WOUNDS, TO SUPPORT ADVOCACY AND EDUCATION INITIATIVES.CVB HAS RECEIVED SUPPORT FROM A DIVERSITY OF DONORS AND SOURCES DURING ITS
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0HRA FORFEITURES - 2020 AMOUNT: $ 28,475. 2021 AMOUNT: $ 0. STIMULUS/COVID CREDITS - 2020 AMOUNT: $ 3,629. 2021 AMOUNT: $ 2,480. OTHER REFUNDS - 2021 AMOUNT: $ 110,255.
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt1BOARD CHAIR AND CEO, MAGALI HAAS, MD, PHD FOUNDED ORION BIONETWORKS (RENAMED TO COHEN VETERANS BIOSCIENCE IN 2015) WITH SPONSORSHIP FROM JANSSEN RESEARCH & DEVELOPMENT TO UNLOCK THE POWER OF SHARED DATA AND PREDICTIVE MODELING TO HELP TRANSFORM OUR UNDERSTANDING OF BRAIN DISEASES AND ACCELERATE THE SEARCH FOR CURES. DR. HAAS HAS OVER 20 YEARS OF PHARMACEUTICAL EXECUTIVE AND CLINICAL RESEARCH EXPERIENCE INCLUDING DEVELOPMENT LEADERSHIP ROLES IN MEDICAL MARKETING, FULL CLINICAL DEVELOPMENT, EARLY DEVELOPMENT, AND TRANSLATIONAL AND BIOMARKER SCIENCES IN PSYCHIATRY AND NEUROLOGY. DURING HER TENURE AT JOHNSON & JOHNSON, SHE SUCCESSFULLY FILED NDAS IN THE US AND EUROPE FOR RISPERIDONE INDICATIONS IN AUTISM, ADOLESCENT SCHIZOPHRENIA, JUVENILE BIPOLAR DISORDER AND CONDUCT DISORDERS. SHE ALSO LED DEVELOPMENT TEAMS EVALUATING COMPOUNDS FOR DEPRESSION, NEUROPATHIC PAIN, EPILEPSY, AND MIGRAINE DISORDER. SHE SERVED 3 YEARS AS CHIEF SCIENCE AND TECHNOLOGY OFFICER FOR ONE MIND FOR RESEARCH, A NONPROFIT ORGANIZATION LAUNCHED IN MAY 2012 BY PATRICK J KENNEDY. SHE ORCHESTRATED THE LAUNCH OF ONE MIND'S SEMINAL PROGRAMS, APOLLO, AN INFORMATICS RESEARCH PORTAL AND, GEMINI, AN INTERNATIONAL TBI/PTSD RESEARCH PROGRAM. AS AN "INTRAPRENEUR" AT J&J SHE ESTABLISHED THE FIRST NEUROSCIENCE TRANSLATIONAL MEDICINE & INTEGRATIVE SOLUTIONS DEPARTMENT, AND CO-FOUNDED THE FIRST COMPANION DIAGNOSTICS CENTER OF EXCELLENCE AS WELL AS J&J'S HEALTHCARE INNOVATION TEAM. SHE SERVES ON SEVERAL ADVISORY BOARDS INCLUDING ALTO NEUROSCIENCE, KREMBIL CENTRE FOR NEUROINFORMATICS, VIRTUALBRAINCLOUD, PARTNERSHIP FOR ASSESSMENT AND ACCREDITATION OF SCIENTIFIC PRACTICE (PAASP) AND INTERUNIVERSITY MICROELECTRONICS CENTRE (IMEC) AN INTERNATIONAL RESEARCH & DEVELOPMENT AND INNOVATION HUB. DR. HAAS EARNED HER BS IN BIOENGINEERING FROM THE UNIVERSITY OF PENNSYLVANIA, AN MS IN BIOMEDICAL ENGINEERING FROM RUTGERS UNIVERSITY, NEW JERSEY, AND HER MD PHD WITH DISTINCTION IN NEUROSCIENCE FROM ALBERT EINSTEIN COLLEGE OF MEDICINE, NEW YORK. BOARD MEMBER, SECRETARY, THERESA FRANGIOSA HAS EXTENSIVE EXECUTIVE EXPERIENCED BASED ON HER 25 YEAR CAREER WITH THE PHARMACEUTICAL SECTOR. IN HER ROLES WITHIN PHARMA, SHE WAS A GLOBAL LAUNCH LEADER AS WELL AS OVERSEEING EARLY COMMERCIAL STRATEGY IN NEUROSCIENCES. SHE LED LARGE SCALE TEAMS, CROSS-FUNCTIONAL TEAMS TO DEFINE DISEASE AND THERAPEUTIC AREA STRATEGIES FOR JANSSEN AND GLAXOSMITHKLINE. SHE HAS ALSO LED INDICATION PRIORITIZATION EFFORTS AND DEVELOPMENT OF OVER 200 TARGET PRODUCT PROFILES OVER A VARIETY OF DISEASE STATES, LEVERAGING WELL-ESTABLISHED PROCESSES AND FRAMEWORKS, INCLUDING DEEPER UNDERSTANDING OF PATIENT JOURNEYS TO CREATE KEY INSIGHTS. SHE HAS APPLIED HER PROFESSIONAL CAREER EXPERIENCE AND HER PASSION FOR ADVOCACY TO HELP CREATE A CHANNEL FOR FEEDBACK FROM THOSE DIAGNOSED WITH OR AT RISK FOR ALZHEIMER'S DISEASE OR DEMENTIA, THEIR CARE PARTNERS AND INDIVIDUALS WHO ARE 'WORRIED WELL', CALLED THE A-LIST. SHE IS THE LEAD INVESTIGATOR FOR THIS RESEARCH STUDY WITH IRB OVERSIGHT. MS. FRANGIOSA OBTAINED HER BACHELOR OF ADMINISTRATION, ACCOUNTING CONCENTRATION FROM URSINUS COLLEGE (COLLEGEVILLE, PA) IN 1988 AND HER MASTERS OF BUSINESS ADMINISTRATION, PHARMACEUTICAL MARKETING FROM ST. JOSEPH'S UNIVERSITY IN 1996. BOARD MEMBER, TREASURER, MICHAEL C. SULLIVAN IS THE CHIEF OF STAFF AND HEAD OF EXTERNAL AFFAIRS OF POINT72 ASSET MANAGEMENT. MR. SULLIVAN PREVIOUSLY SERVED AS A SENIOR AIDE IN THE UNITED STATES SENATE, FOCUSING ON TELECOM, TECHNOLOGY, AND FINANCE ISSUES. MR. SULLIVAN ALSO SERVED AS A STAFF MEMBER IN THE U.S. HOUSE OF REPRESENTATIVES WORKING ON SIMILAR ISSUES. BEFORE COMING TO CAPITOL HILL, MR. SULLIVAN WAS THE HEAD OF STRATEGIC DEVELOPMENT FOR A TELECOMMUNICATIONS FOCUSED TRADE ASSOCIATION. MR. SULLIVAN IS INVOLVED WITH SEVERAL VETERANS' MENTAL HEALTH-RELATED NON-PROFIT ORGANIZATIONS. HE HELPED ESTABLISH AND SERVES ON THE BOARD AND AS TREASURER OF THE COHEN VETERANS NETWORK, WHICH OPERATES A NATIONAL NETWORK OF CLINICS TO TREAT VETERANS
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc1PART II SECT C LINE 17A FACTS & CIRCUMSTANCES TEST (CONT):
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt017941055
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt016160581
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt016316026
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt020795052
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt016828176
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt088040890
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt028608
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt059585

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2022 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$15,587,351
Liabilities
$3,699,826
Net assets
$11,887,525
Revenue
$18,082,398
Expenses
$17,523,784
Net income
$558,614
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.84$0.10$1.74$3.37$1.38$1.99
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.08$3.11$0.03$8.38$14.1$5.70
2023Facts available. Structured filing facts are available, but richer extracted sections are limited.$11.7$3.85$7.89$11.3$15.3$4.00
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$15.6$3.70$11.9$18.1$17.5$0.56
2022Detailed filing. Detailed filing data is available for this year.$15.6$3.70$11.9$18.1$17.5$0.56
2021Facts available. Structured filing facts are available, but richer extracted sections are limited.$18.0$6.83$11.1$16.3$18.1$1.86
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$18.9$8.43$10.4$16.5$18.2$1.69
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$24.2$13.0$11.2$21.0$20.2$0.87
2018Facts available. Structured filing facts are available, but richer extracted sections are limited.$16.4$6.02$10.3$16.8$14.8$2.05
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$14.9$6.58$8.28$4.37$11.3$6.97
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$25.4$10.2$15.3$31.4$16.3$15.1
2015Detailed filing. Detailed filing data is available for this year.$0.45$0.33$0.12$0.07$0.65$0.58